Literature DB >> 9352021

Lethal outcome of uterine infection in pregnant but not in nonpregnant rats and increased death rate with inhibition of nitric oxide.

B Nowicki1, L Fang, J Singhal, S Nowicki, C Yallampalli.   

Abstract

PROBLEM: Limited information is available on potential differences in sensitivity to urogenital infections between pregnant and nonpregnant hosts. METHOD OF STUDY: In this study, we evaluated Escherichia coli infectious complications in pregnant and nonpregnant rats and the effect of nitric oxide (NO) inhibitor, NG-nitro-L-arginine methyl ester (L-NAME), on the outcome of an experimental uterine infection.
RESULTS: Of the infected pregnant animals, 31% were found dead in 24-48 hr. The death rate was increased 2-fold (66%) with L-NAME treatment. No deaths occurred in nonpregnant animals with or without L-NAME treatment. The rate of uterine infection in pregnant animals was about 10-fold higher than in nonpregnant animals.
CONCLUSION: We propose that infectious complications of pregnancy may be related to gestation-dependent sensitivity to the pathogenic microorganism and the host NO status.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9352021     DOI: 10.1111/j.1600-0897.1997.tb00521.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  15 in total

1.  Inverse relationship between severity of experimental pyelonephritis and nitric oxide production in C3H/HeJ mice.

Authors:  B Nowicki; J Singhal; L Fang; S Nowicki; C Yallampalli
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Prophylactic herbal therapy prevents experimental ascending urinary tract infection in mice.

Authors:  Yan-Qing Tong; Min Sun; Ying Chi
Journal:  Chin J Integr Med       Date:  2016-07-19       Impact factor: 1.978

3.  Vaccination with purified Dr Fimbriae reduces mortality associated with chronic urinary tract infection due to Escherichia coli bearing Dr adhesin.

Authors:  Pawel Goluszko; Elzbieta Goluszko; Bogdan Nowicki; Stella Nowicki; Vsevolod Popov; Hui-Qun Wang
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

4.  Maternal/fetal mortality and fetal growth restriction: role of nitric oxide and virulence factors in intrauterine infection in rats.

Authors:  Katarzyna Wroblewska-Seniuk; Stella Nowicki; Chantal Le Bouguénec; Bogdan Nowicki; Chandra Yallampalli
Journal:  Am J Obstet Gynecol       Date:  2011-02-23       Impact factor: 8.661

5.  Dr operon-associated invasiveness of Escherichia coli from pregnant patients with pyelonephritis.

Authors:  P Goluszko; D Niesel; B Nowicki; R Selvarangan; S Nowicki; A Hart; E Pawelczyk; M Das; P Urvil; R Hasan
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

6.  Experimental gestational pyelonephritis induces preterm births and low birth weights in C3H/HeJ mice.

Authors:  A K Kaul; S Khan; M G Martens; J T Crosson; V R Lupo; R Kaul
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 7.  Pathogenesis of Afa/Dr diffusely adhering Escherichia coli.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 8.  Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

9.  Epithelial invasion by Escherichia coli bearing Dr fimbriae is controlled by nitric oxide-regulated expression of CD55.

Authors:  Li Fang; Bogdan J Nowicki; Petri Urvil; Pawel Goluszko; Stella Nowicki; Steven L Young; Chandrasekhar Yallampalli
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

10.  Preterm labor: CD55 in maternal blood leukocytes.

Authors:  Stella Nowicki; Michael G Izban; Edyta Pawelczyk; Vincent K Agboto; Siddarth Pratap; Gayle Olson; Bogdan Nowicki
Journal:  Am J Reprod Immunol       Date:  2009-05       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.